ACTIVE

Tools4Patient

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-3,7 M €-27,7 %over 1 year

Gross margin-431 k €-152,2 %over 1 year

Equity19,5 M €+12,2 %over 1 year

Workforce16,2 ETP0,0 %over 1 year

Identity

Source · BCE/KBO

Tools4Patient is a Public limited company incorporated in 2013. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Mont-Saint-Guibert. It employs on average 16,2 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0534.842.954
Incorporation: 31/05/2013
Legal form: Public limited company
Registered office: Rue Granbonpré 11 box 9
1435 Mont-Saint-Guibert · WallonieSee on map
Contributed capital: 29 359 852,00 €
Latest accounts: 31/12/2025
Average workforce: 16,2 ETP

Activities (NACE)

72101Research and experimental development on natural sciences and engineering· main 72110Research and experimental development on biotechnology 72200Research and experimental development on social sciences and humanities 72200Research and experimental development on social sciences and humanities 62090Other information technology and computer service activities 62900Computer programming, consultancy and related activities+2

Joint committees (1)

Signals

Solid equityHealthy social debts

Financials

Source · NBB, 13 filings

Trend over 12 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	-431 k €	-152%	825,5 k €	-58.5%	2 M €	+36.0%	1,5 M €	+15.5%	1,3 M €
EBITDA	-2,5 M €	-41.7%	-1,7 M €	-1022%	189,5 k €	+157%	-331,1 k €	-12.1%	-295,4 k €
Operating result	-3,8 M €	-30.3%	-2,9 M €	-304%	-730,5 k €	+38.7%	-1,2 M €	-2.7%	-1,2 M €
Net result	-3,7 M €	-27.7%	-2,9 M €	-174%	-1,1 M €	+12.0%	-1,2 M €	+5.9%	-1,3 M €
Balance sheet
Equity	19,5 M €	+12.2%	17,4 M €	+62.9%	10,7 M €	-10.2%	11,9 M €	-10.2%	13,2 M €
Total assets	23,1 M €	+5.3%	22 M €	+6.1%	20,7 M €	+8.6%	19,1 M €	+5.5%	18,1 M €
Cash	622,5 k €	+26.6%	491,6 k €	+401642%	122,4 €	-99.3%	18,6 k €	-96.8%	574,2 k €
Debts	3,6 M €	-21.1%	4,5 M €	-54.8%	10 M €	+39.0%	7,2 M €	+49.4%	4,8 M €
Other
Workforce	16,2 ETP	0.0%	16,2 ETP	+3.2%	15,7 ETP	-2.5%	16,1 ETP	-5.8%	17,1 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

5 active · 15 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
EDITH COUNE	Directorsince 08/04/2024
OLIVIER HOUBEN	Directorsince 08/04/2024
SPARAXIS0452.116.307Represented by SOPHIE SAUVAGE	Directorsince 08/04/2024
YVES VANDEKERCKHOVE	Directorsince 22/02/2018
NOVICREO0885.428.866Represented by DOMINIQUE DEMOLLE	Managing directorsince 29/05/2013

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
CHRISTIAN JOURQUIN	Director13/12/2021 → 2023 accounts
FONDS DE CAPITAL A RISQUE 20200667.964.566Represented by HELENA POZIOS	Director18/06/2019 → 2020 accounts

Other companies at this address

Rue Granbonpré 11 1435 Mont-Saint-Guibert

Company	CBE no.
Ascend Performance Materials● Active	0810.113.316
Ascend Performance Materials Belgium Holdco● Active	1012.379.397
AUDANE INVEST● Active	0816.921.429
BiocSol● Active	1003.683.546
CEDRIC CLAERHOUDT● Active	0477.799.927
Cellaïon● Liquidation	0764.522.425
Clinigen Clinical Supplies Management● Active	0859.906.087
Cronos Sud● Active	1014.190.824
DE SMET AGRO● Active	0402.951.757
DE SMET S.A. - ENGINEERS & CONTRACTORS● Active	0438.987.752
FLEXSO BRUSSELS● Active	0898.889.892
Keiro● Active	0681.490.821
NOVADIP BIOSCIENCES● Active	0535.575.602
PARLYM BELGIUM● Active	1028.144.372
PARSMET MANAGEMENT● Active	1025.167.858
PROMETHERA BIOSCIENCES● Bankrupt	0809.788.365
TFP IMMO● Active	1032.940.330
The Akkermansia Company● Active	0664.529.083
THE TORREFACTORY PROJECT● Active	0679.686.720
VAT Group Ascend● Active	1002.911.308

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	22/06/2026	07/07/2025	26/07/2024	02/08/2023	28/07/2022	07/10/2021
General meeting	16/06/2026	17/06/2025	25/06/2024	20/06/2023	12/07/2022	15/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 13 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	16/06/2026	22/06/2026	French	PDF
Abridged model	31/12/2024	17/06/2025	07/07/2025	French	PDF
Abridged model	31/12/2023	25/06/2024	26/07/2024	French	PDF
Abridged model	31/12/2022	20/06/2023	02/08/2023	French	PDF
Abridged model	31/12/2021	12/07/2022	28/07/2022	French	PDF
Abridged modelCorrection	31/12/2020	15/06/2021	07/10/2021	French	PDF
Abridged model	31/12/2020	15/06/2021	03/08/2021	French	PDF
Abridged model	31/12/2019	03/09/2020	04/09/2020	French	PDF
Abridged model	31/12/2018	18/06/2019	25/06/2019	French	PDF
Abridged model	31/12/2017	19/06/2018	21/06/2018	French	PDF
Abridged model	31/12/2016	13/06/2017	04/07/2017	French	PDF
Abridged model	31/12/2015	21/06/2016	01/08/2016	French	PDF
Abridged model	31/12/2014	16/06/2015	26/07/2015	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

5 active · 15 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
EDITH COUNE	Directorsince 08/04/2024
OLIVIER HOUBEN	Directorsince 08/04/2024
SPARAXIS0452.116.307Represented by SOPHIE SAUVAGE	Directorsince 08/04/2024
YVES VANDEKERCKHOVE	Directorsince 22/02/2018
NOVICREO0885.428.866Represented by DOMINIQUE DEMOLLE	Managing directorsince 29/05/2013

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
CHRISTIAN JOURQUIN	Director13/12/2021 → 2023 accounts
FONDS DE CAPITAL A RISQUE 20200667.964.566Represented by HELENA POZIOS	Director18/06/2019 → 2020 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Capital / shares23/01/2025
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
PDF
Other23/12/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates03/07/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates11/04/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
PDF
Mandates23/02/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates28/12/2021
SIEGE SOCIAL - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates19/10/2020
DEMISSIONS, NOMINATIONS
PDF
Mandates18/12/2019
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings12 filings

Mandates

SPARAXIS

EDITH COUNE

OLIVIER HOUBEN

YVES VANDEKERCKHOVE

NOVICREO

CHRISTIAN JOURQUIN

FONDS DE CAPITAL A RISQUE 2020

HELENA POZIOS

HANS HERPOEL

MARC NOLET de BRAUWERE van STEENLAND

YVES VANDEKERCHOVE

MARC NOLET DE BRAUWERE VAN STEELAND

Show the 8 other mandates

20132014201520162017201820192020202120222023202420252026

Tools4Patient

Rue Granbonpré 11 bte 9, 1435 Mont-Saint-Guibert

Director

Managing director

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Rue Granbonpré 11 bte 9, 1435 Mont-Saint-GuibertCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00182424

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
Tools4PatientCurrent	accounts 2014 → 2025	Accounts 2025 · 2026-00182424

Events

2025
Annual accounts 2025-3,7 M €↓
2024
Annual accounts 2024-2,9 M €↓
2023
Annual accounts 2023-1,1 M €↑
2022
Annual accounts 2022-1,2 M €↑
2021
Annual accounts 2021-1,3 M €↓
2020
Annual accounts 2020-160,9 k €↑
2019
Annual accounts 2019-519 k €↓
2018
Annual accounts 2018-320,4 k €↓
2017
Annual accounts 2017-229 k €
2016
Annual accounts 2016
2015
Annual accounts 2015
2014
Annual accounts 2014
31/05/2013
IncorporationPublic limited company

Tools4Patient

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events